Trends and Insights

The digital health solutions landscape is rapidly evolving, with payers, manufacturers, and patients recognizing the value that digital products offer as a new modality of disease management and treatment. This newsletter will deliver forward visibility and provide insight into the latest developments in the digital health space.¹

At the end of March, the FDA released a framework to address the long-standing questions on the use of digital health technologies (DHTs) in clinical drug trials. Though not an official guidance document, this roadmap is one step closer in the FDA’s commitment to clarify its stance on the value of DHT and before the end of the year, we expect further draft guidances from the FDA.²

A decline in Medicare Advantage star ratings will cost CVS Health up to $1 billion in revenue in 2024, signaling a need for additional interventions to improve the member experience. Digital health solutions can help by improving member experience scores.³

Measures are inconsistent, complex, and often redundant across the Centers for Medicare & Medicaid Services’ quality programs. The Universal Foundation was formed to align quality measures between programs and offer standardized measures that lend themselves to interoperable digital data.⁴ 

The Peterson Center on Healthcare has launched the Peterson Health Technology Institute to evaluate the performance of digital health technologies—payers can expect a higher standard of digital health purchasing and evidence generation to support coverage decisions.⁵ 

As more digital health solutions enter the market, stakeholders recognize that aligning with common adherence and engagement metrics will enable more meaningful comparisons among solutions,
studies, and patient populations.⁶

Patients who are actively involved in their healthcare tend to incur 8.3% lower costs than those who are less engaged; with Dario, MedOne aims to find engagement across a multitude of means.⁷

Sanofi’s real-world studies in digital health compared user and non-user cohorts to clearly understand the potential clinical and economic impact of Dario’s diabetes management solution.⁸

This study reviews the confidence levels of individuals with type 2 diabetes (T2D) of their self-management.⁹

Trust building was analyzed for user-centered digital healthcare launch strategies that focus on self-efficacy and balance.¹⁰

Additional education around connected digital ecosystems may be needed.¹¹

Findings from this systematic literature review analyzed the impact of high-intensity coaching in digital interventions for the self-management of T2D defined by the availability and level of personalization.¹²

Diabetes is a chronic condition that affects millions of individuals in the United States and can amount to billions of dollars in estimated direct medical costs.¹³

Digital healthcare technology that provides personalized interventions can reduce medical costs.^14​​​​​​​

To establish a balanced and connected digital diabetes ecosystem, the authors of this paper proposed a roadmap with key milestones that need to be delivered along the way.¹⁵